FindTrial
Sign In

A study to compare the duration of pain free period after surgery when Butorphanol and Tramadol given with Levobupivacaine in brachial plexus block

Efficacy of Butorphanol and Tramadol as adjuvant to Levobupivacaine for postoperative analgesia in brachial plexus block- A randomized double blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041666
Enrollment
100
Registered
2022-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S529- Unspecified fracture of forearm

Interventions

Intervention1: Inj Butorphanaol: Butorphanol 2mg with 20 ml of 0.5% Levobupivacaine in brachial plexus block Intervention2: Inj Tramadol: Tramadol 100 mgwith 20 ml of 0.5% Levobupivacaine in brachial

Sponsors

Dr Jaya Lalwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I to III 2. Patients undergoing elective below elbow upper limb surgery under ultra sound guided supraclavicular brachial plexus block

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Local infection at injection site 3. Failure of block 4. Any bleeding disorder and patient on anticoagulants 5. Allergy to study drugs 6. Severe respiratory, renal and liver disorder 7. Glucose intolerance and diabetic patient 8. Neurological deficit involving brachial plexus 9. Morbidly obese 10. Pregnant women 11. Drug abuse

Design outcomes

Primary

MeasureTime frame
Duration of postoperative analgesia Timepoint: First 24 hours of postoperative period—

Secondary

MeasureTime frame
â®? Assessment of pain using VAS â®? Onset of sensory and motor blockade â®? Duration of sensory and motor blockade â®? Adverse effectsâ?? CNS toxicity [convulsion, coma], CVS toxicity [tachycardia, arrhythmias], respiratory depression, nausea, vomiting, allergic reactions, pneumothorax, Horners syndrome and recurrent laryngeal nerve block. Timepoint: First 24 hours of postoperative period—

Countries

India

Contacts

Public ContactDr Jaya Lalwani

Pt JNM Medical College Raipur

jayalalwani2020@gmail.com9300224989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026